insights_auto
Zakaj je tečaj DRREDDY padel 2,51%?
Podrobneje raziščichevron_right
DRREDDY:NSE
Dr Reddy's Laboratories Ltd
1.202,00 ₹
arrow_downward
−2,51%(−31,00) 1D
1. okt., 15:30:00 GMT +5.30 · INR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za DRREDDY …
Odpri
1.233,00 ₹
Visoka
1.233,90 ₹
Nizka
1.194,90 ₹
Tržna kapitalizacija
1,00 bil.
Povprečni promet
1,67 mio.
Promet
2,61 mio.
Dividenda
0,67 %
Četrtletna dividenda
2,00 ₹
Prvi trgovalni dan brez upravičenja do dividende
10. jul. 2026
Razmerje med ceno delnice in čistim dobičkom
31,08
52-tedenski najvišji tečaj
1.414,90 ₹
52-tedenski najnižji tečaj
1.101,00 ₹
Čisti dobiček na delnico
38,67 ₹
Št. izdanih delnic
166,06 mio.
Št. zaposlenih
28 tis.
Odpri
1.233,00 ₹
Visoka
1.233,90 ₹
Nizka
1.194,90 ₹
Tržna kapitalizacija
1,00 bil.
Povprečni promet
1,67 mio.
Promet
2,61 mio.
Dividenda
0,67 %
Četrtletna dividenda
2,00 ₹
Prvi trgovalni dan brez upravičenja do dividende
10. jul. 2026
Razmerje med ceno delnice in čistim dobičkom
31,08
52-tedenski najvišji tečaj
1.414,90 ₹
52-tedenski najnižji tečaj
1.101,00 ₹
Čisti dobiček na delnico
38,67 ₹
Št. izdanih delnic
166,06 mio.
Št. zaposlenih
28 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Business Wire
·
pred 1 uro
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Simply Wall Street
·
pred 24 minutami
Netflix (NFLX) Draws Bill Ackman Back As Studio Bid Raises The Stakes
PR Newswire
·
pred 1 uro
NeuroSense Provides Update on Nasdaq Listing Compliance
Yahoo Finance
·
pred 1 uro
Alarm.com (NASDAQ:ALRM) Q2 Earnings: Leading The Vertical Software Pack
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Vizitka: Dr Reddy's Laboratories Ltd
Generalni direktorErez Israeli
Št. zaposlenih27,5 tis.
Ustanovljeno1984
SedežHyderabad, Andra Pradeš, Indija
Sektor-
Spletno mestodrreddys.com